These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7958278)

  • 1. Inhibition of isoenzymes of dog heart phosphodiesterase by blue, yellow and red triazine dyes.
    Clapham JC; Wilderspin AF
    Biochem Soc Trans; 1994 May; 22(2):216S. PubMed ID: 7958278
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.
    Zimmermann W; Scholz H; Schumacher C; Wenzlaff H; Haverich A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):611-8. PubMed ID: 7526225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes.
    Sharma RK; Kalra J
    Biochemistry; 1993 May; 32(19):4975-8. PubMed ID: 8388250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses.
    Hall IP
    Br J Clin Pharmacol; 1993 Jan; 35(1):1-7. PubMed ID: 8383516
    [No Abstract]   [Full Text] [Related]  

  • 7. cGMP inhibition of heart phosphodiesterase: is it clinically relevant?
    Beavo JA
    J Clin Invest; 1995 Feb; 95(2):445. PubMed ID: 7860725
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
    Kyoi T; Oka M; Noda K; Ukai Y
    Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
    Kakkar R; Raju RV; Rajput AH; Sharma RK
    Brain Res; 1997 Feb; 749(2):290-4. PubMed ID: 9138729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitor.
    Ukita T; Nakamura Y; Kubo A; Yamamoto Y; Takahashi M; Kotera J; Ikeo T
    J Med Chem; 1999 Apr; 42(7):1293-305. PubMed ID: 10197972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in cyclic nucleotide phosphodiesterase research: isozymes, functions, and inhibitors].
    Kotera J; Sasaki T; Omori K
    Nihon Yakurigaku Zasshi; 2005 Aug; 126(2):121-7. PubMed ID: 16205015
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel triazines as potent and selective phosphodiesterase 10A inhibitors.
    Malamas MS; Stange H; Schindler R; Lankau HJ; Grunwald C; Langen B; Egerland U; Hage T; Ni Y; Erdei J; Fan KY; Parris K; Marquis KL; Grauer S; Brennan J; Navarra R; Graf R; Harrison BL; Robichaud A; Kronbach T; Pangalos MN; Brandon NJ; Hoefgen N
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5876-84. PubMed ID: 22902656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical evolution of autotaxin inhibitors.
    Albers HM; Ovaa H
    Chem Rev; 2012 May; 112(5):2593-603. PubMed ID: 22335786
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.
    Torphy TJ
    Am J Respir Crit Care Med; 1998 Feb; 157(2):351-70. PubMed ID: 9476844
    [No Abstract]   [Full Text] [Related]  

  • 15. Difference spectroscopic and kinetic studies on the interaction of lactate dehydrogenase with structurally related triazine dyes.
    Cadelis F; Kirchberger J; Vijayalakshmi MA; Kopperschläger G
    Biomed Biochim Acta; 1991; 50(12):1167-76. PubMed ID: 1824535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zardaverine as a selective inhibitor of phosphodiesterase isozymes.
    Schudt C; Winder S; Müller B; Ukena D
    Biochem Pharmacol; 1991 Jun; 42(1):153-62. PubMed ID: 1648920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of the novel phosphodiesterase IV inhibitor RP 73401.
    Karlsson JA; Souness J; Webber S; Pollock K; Raeburn D
    Int Arch Allergy Immunol; 1995; 107(1-3):425-6. PubMed ID: 7613200
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyclic nucleotides phosphodiesterases inhibitors].
    Hagiwara M; Hidaka H
    Nihon Rinsho; 1991 Sep; 49(9):1993-8. PubMed ID: 1660084
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific inhibition of L-type pyruvate kinase by the triazine dye Procion Blue MX-R.
    Byford MF; Bloxham DP
    Biochem J; 1984 Oct; 223(2):359-67. PubMed ID: 6497854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of ferredoxin-NADP+ oxidoreductase with triazine dyes. A rapid purification method by affinity chromatography.
    Carrillo N; Vallejos RH
    Biochim Biophys Acta; 1983 Jan; 742(2):285-94. PubMed ID: 6824690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.